Paclitaxel
Paclitaxel is a laboratory reagent produced by LKT Laboratories. It is a naturally occurring compound isolated from the bark of the Pacific yew tree. Paclitaxel inhibits cell division by stabilizing microtubules, which are essential components of the cellular cytoskeleton.
Lab products found in correlation
5 protocols using paclitaxel
Trastuzumab-Paclitaxel Nanoconjugate Synthesis
Inhibition of NF-κB and Ghrelin Signaling in Paclitaxel-Treated Rats
Paclitaxel was injected intraperitoneally (i.p.) at a dose of 2 or 5 mg/kg. PDTC was injected intrathecally (i.t.) at a dose of 100 ng/5μL. [D-Lys3]-GHRP-6 was injected i.p. at a dose of 10 mg/kg. RKT was administered orally (p.o.) at a dose of 0.1, 0.3, or 1 g/kg. Control animals were injected with the respective vehicle for each drug.
Synergistic Chemo-Statin Combination Protocol
Endometrial Cancer Cell Lines: Authentication and Culture
Drug Screening and Cellular Assay Protocol
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!